Alerts will be sent to your verified email
Verify Email
THEMISMED
|
Themis Medicare
|
NGL Fine-Chem
|
Shree Ganesh Remed.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.48 % | 18.68 % | 20.54 % |
|
5yr Avg Net Profit Margin
|
13.75 % | 12.56 % | 19.4 % |
|
Price to Book
|
2.29 | 3.17 | 5.22 |
|
P/E
|
0.0 | 42.94 | 34.62 |
|
5yr Avg Cash Conversion Cycle
|
62.99 Days | 24.74 Days | 74.82 Days |
|
5yr Average Interest Coverage Ratio
|
7.27 | 25.7 | 37.3 |
|
5yr Avg ROCE
|
17.31 % | 24.83 % | 25.4 % |
|
5yr Avg Operating Profit Margin
|
18.07 % | 18.08 % | 28.41 % |
|
5 yr average Debt to Equity
|
0.28 | 0.16 | 0.17 |
|
5yr CAGR Net Profit
|
-3.53 % | -18.08 % | 29.89 % |
|
5yr Average Return on Assets
|
9.9 % | 13.76 % | 15.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.15 % | 72.74 % | 72.8 % |
|
Share Pledged by Promoters
|
2.43 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.03 % | -1.07 % | 3.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Themis Medicare
|
NGL Fine-Chem
|
Shree Ganesh Remed.
|
|---|